Amphastar Pharmaceuticals, Inc. (AMPH)
26.78
-0.22
(-0.81%)
USD |
NASDAQ |
Dec 31, 16:00
26.78
0.00 (0.00%)
After-Hours: 20:00
Amphastar Pharmaceuticals EPS Diluted (Quarterly): 0.3639 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Eli Lilly & Co. | 6.211 |
| Align Technology, Inc. | 0.7837 |
| Ionis Pharmaceuticals, Inc. | -0.805 |
| CorMedix, Inc. | 1.259 |
| Supernus Pharmaceuticals, Inc. | -0.7978 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 17.35M |
| Revenue (Quarterly) | 191.84M |
| Total Expenses (Quarterly) | 174.49M |
| Enterprise Value | 1.609B |
| Gross Profit Margin (Quarterly) | 49.53% |
| Profit Margin (Quarterly) | 9.04% |
| Earnings Yield | 8.42% |
| Operating Earnings Yield | 11.37% |
| Normalized Earnings Yield | 8.330 |